| 20.96 0.79 (3.92%) | 10-05 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 28.51 | 1-year : | 31.81 |
| Resists | First : | 24.41 | Second : | 27.23 |
| Pivot price | 22.74  |
|||
| Supports | First : | 19.85 | Second : | 16.51 |
| MAs | MA(5) : | 21.8 |
MA(20) : | 23.11 |
| MA(100) : | 20.38  |
MA(250) : | 18.26 |
|
| MACD | MACD : | -0.4 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 13 |
D(3) : | 21 |
| RSI | RSI(14): 40.7 |
|||
| 52-week | High : | 27.23 | Low : | 11.36 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ PRE ] has closed above bottom band by 9.4%. Bollinger Bands are 19.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 21.37 - 21.48 | 21.48 - 21.58 |
| Low: | 20.07 - 20.18 | 20.18 - 20.28 |
| Close: | 20.79 - 20.96 | 20.96 - 21.13 |
Prenetics Global Limited is a consumer health sciences company that has pivoted to focus on a consumer health and longevity platform. The company's main brand is IM8, which offers science-backed nutritional supplements. It also operates CircleDNA, a consumer genetic testing brand that provides personalized health reports based on sequencing technology.
Tue, 06 Oct 2026
Form 4 Prenetics Global Ltd For: 6 October By Investing.com - Investing.com India
Tue, 06 Oct 2026
A 2,000-share grant settlement leaves Prenetics Global (PRE) director holding 8,001 shares. - Stock Titan
Fri, 02 Oct 2026
Is Prenetics Global Ltd (PRE) a Bargain After 8.1% Drop? GF Value Says Undervalued - gurufocus.com
Fri, 02 Oct 2026
After acquiring 7,635 shares, Prenetics (PRE) CFO Hoi Chun Lo holds 573,648 shares. - Stock Titan
Mon, 24 Aug 2026
Prenetics Global: Marketing Mastery The Key To Robust Revenue Growth (NASDAQ:PRE) - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Consumer Defensive
|
|
|
Industry:
Household & Personal Products
|
|
| Shares Out | 15 (M) |
| Shares Float | 13 (M) |
| Held by Insiders | 14.5 (%) |
| Held by Institutions | 7.8 (%) |
| Shares Short | 590 (K) |
| Shares Short P.Month | 666 (K) |
| EPS | -3.47 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 5.38 |
| Profit Margin | -30.4 % |
| Operating Margin | -45.2 % |
| Return on Assets (ttm) | -19 % |
| Return on Equity (ttm) | -47.1 % |
| Qtrly Rev. Growth | 210.6 % |
| Gross Profit (p.s.) | 5.87 |
| Sales Per Share | 10.17 |
| EBITDA (p.s.) | -3.56 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -40 (M) |
| Levered Free Cash Flow | -36 (M) |
| PE Ratio | -6.06 |
| PEG Ratio | 0 |
| Price to Book value | 3.88 |
| Price to Sales | 2.06 |
| Price to Cash Flow | -7.87 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|